Blackboxstocks (BLBX) – E*Trade Integration and Mobile App Launch

Wednesday, May 04, 2022

Blackboxstocks (BLBX)
E*Trade Integration and Mobile App Launch

Blackboxstocks, Inc. is a financial technology and social media hybrid platform offering real-time proprietary analytics and news for stock and options traders of all levels. Our web-based software employs “predictive technology” enhanced by artificial intelligence to find volatility and unusual market activity that may result in the rapid change in the price of a stock or option. Blackbox continuously scans the NASDAQ, New York Stock Exchange, CBOE, and all other options markets, analyzing over 10,000 stocks and up to 1,500,000 options contracts multiple times per second. We provide our users with a fully interactive social media platform that is integrated into our dashboard, enabling our users to exchange information and ideas quickly and efficiently through a common network. We recently introduced a live audio/video feature that allows our members to broadcast on their own channels to share trade strategies and market insight within the Blackbox community. Blackbox is a SaaS company with a growing base of users that spans 42 countries; current subscription fees are $99.97 per month or $959.00 annually. For more information, go to: www.blackboxstocks.com .

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

A Busy Day. Blackboxstocks’ management recently announced the release of the Company’s native mobile app on the iOS and Android app stores, as well as the integration with E*TRADE with the Blackbox platform.

Mobile App Launch. The Company officially completed the development of the Blackbox app and released it on Apple and Android phones. Recall, the app utilizes most of the features of the desktop site (over 90% according to the Company) while also giving the user real time alerts on their device even when not actively using the app….

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Euroseas (ESEA) – Euroseas agrees to buy two container vessels

Wednesday, May 04, 2022

Euroseas (ESEA)
Euroseas agrees to buy two container vessels

Euroseas Ltd. was formed on May 5, 2005 under the laws of the Republic of the Marshall Islands to consolidate the ship owning interests of the Pittas family of Athens, Greece, which has been in the shipping business over the past 140 years. Euroseas trades on the NASDAQ Capital Market under the ticker ESEA. Euroseas operates in the container shipping market. Euroseas’ operations are managed by Eurobulk Ltd., an ISO 9001:2008 and ISO 14001:2004 certified affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. Euroseas employs its vessels on spot and period charters and through pool arrangements.

Michael Heim, CFA, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Euroseas agreed to acquire two 4,250 teu container vessels for a combined price of $37 million. The acquisitions increase ESEA’s fleet to 18 vessels with 54,621 teu with an additional 7  newbuildings and 16,600 teu to be delivered in 2023-24. The price per teu is in line with recent prices, which have skyrocketed in the last 18 months as shipping rates have risen.

Euroseas has locked in shipping sales contracts to assure the acquisitions are immediately accretive to EBITDA. The M/V Seaspan Manila ship has a contract through February 2025 at prices near $20,000 (with ceiling and floor pricing after April 2024). The M/V Seaspan Melbourne has a contract until  March 2025 at $19,000/day. Combined, management believes the ships will add $20 million to EBITDA, or approximately $2.75 per share….

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Comstock Mining (LODE) – Going All In

Wednesday, May 04, 2022

Comstock Mining (LODE)
Going All In

Comstock (NYSE: LODE) innovates technologies that contribute to global decarbonization and circularity by efficiently converting under-utilized natural resources into renewable fuels and electrification products that contribute to balancing global uses and emissions of carbon. The Company intends to achieve exponential growth and extraordinary financial, natural, and social gains by building, owning, and operating a fleet of advanced carbon neutral extraction and refining facilities, by selling an array of complimentary process solutions and related services, and by licensing selected technologies to qualified strategic partners. To learn more, please visit www.comstock.inc.

Mark Reichman, Senior Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Focusing on its mission. Comstock Mining hosted a webcast to discuss first quarter results and recent developments. The company is going all in on technologies that enable systemic decarbonization. Its renewable fuels division is advancing technologies to commercialize the conversion of woody biomass into advanced cellulosic fuels. Its lithium-ion battery (LIB) recycling business, LiNiCo, is commercializing a process to crush and separate lithium-ion batteries, extract lithium, nickel, cobalt, and graphite, and use the recovered metals to produce 99% pure cathode active precursor products.

Making significant headway. Comstock is currently building commercial pilot scale cellulosic fuels and LIB facilities, and the company is preparing to commence crushing and separating operations that will produce mineral-rich black mass at its 137,000 square foot LIB recycling facility later this year and deploy lithium extraction in the same facility next year. The company’s pilot scale cellulosic fuel system will also be operational at its Wisconsin facility later this year. Comstock has established a near-term goal to commission its first 100 million gallon biorefinery by 2025 and LiNiCo expects to produce marketable, battery-grade lithium carbonate by the end of the second quarter of 2023….

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Release – Euroseas Ltd. Announces Agreement to Acquire two 4,250 teu Container Vessels, built in 2005 and 2007



Euroseas Ltd. Announces Agreement to Acquire two 4,250 teu Container Vessels, built in 2005 and 2007

Research, News, and Market Data on Euroseas Ltd

ATHENS, Greece, May 03, 2022 (GLOBE NEWSWIRE) — Euroseas Ltd. (NASDAQ: ESEA, the “Company” or “Euroseas”), an owner and operator of container vessels and provider of seaborne transportation for containerized cargoes, announced today that it has agreed to acquire M/V Seaspan Manila and M/V Seaspan Melbourne both intermediate size container vessels with capacity of 4,250 teu each built in 2007 and 2005, respectively. The vessels are being acquired for a combined price of $37 million. The Company will also assume the existing charter arrangements of the vessels. Both acquisitions will be initially financed with the Company’s own funds. Specifically:

  • M/V Seaspan Manila is expected to be delivered to the Company within July 2022 and has a charter contract until February 2025 at a rate which is $20,250 per day until April 2024 and, subsequently, based on the CONTEX index with a floor of $13,000 per day and a ceiling of $21,000 per day until the end of the charter period.
  • M/V Seaspan Melbourne is expected to be delivered to the Company within June 2022 and has a charter contract until March 2025 at a rate of $19,000 per day.

Aristides Pittas,
Chairman and CEO of Euroseas commented
:
“We are pleased to announce the acquisition of M/V Seaspan Manila and M/V Seaspan Melbourne, two intermediate containerships built in 2007 and 2005, respectively, along with their existing approximately two years and three quarters long charters. These charters are expected to contribute in excess of about $20 million of EBITDA, bringing the cost basis of the vessels to scrap price levels by the end of the charters while providing a significant contribution to our profitability. Furthermore, depending on the market after the end of the charters in early 2025, we may enjoy significant additional upside if the containership markets are even just at historically average levels. As we have stated in the past, our fleet growth strategy is focused on acquisitions with such a low risk profile alongside our newbuilding program.

“After the delivery of the above vessels, we will have a fleet of eighteen containerships on the water and a newbuilding program of seven feeder containerships which are expected to be completed between the first quarter of 2023 and the second quarter of 2024, expanding our footprint in the sector and solidifying our position as the main US publicly listed company focusing on feeder and intermediate container vessels.”

Fleet Profile:

After the acquisition of M/V “Seaspan Melbourne” and M/V “Seaspan Manila”, the Euroseas Ltd. fleet and employment profile will be as follows:

Vessels
under construction

Type

Dwt

TEU

To be delivered

H4201

Feeder

37,237

2,800

Q1 2023

H4202

Feeder

37,237

2,800

Q2 2023

H4236

Feeder

37,237

2,800

Q4 2023

H4237

Feeder

37,237

2,800

Q1 2024

H4248

Feeder

22,262

1,800

Q2 2024

H4249

Feeder

22,262

1,800

Q2 2024

H4250

Feeder

22,262

1,800

Q2 2024

Notes:
(*)        TC denotes time charter. Charter duration indicates the earliest redelivery date; all dates listed are the earliest redelivery dates under each TC unless the contract rate is lower than the current market rate in which cases the latest redelivery date is assumed; vessels with the latest redelivery date shown are marked by (+).
(**)      CONTEX stands for the Container Ship Time Charter Assessment Index.
(***)     Rate is net of commissions (which are typically 5-6.25%)

About Euroseas Ltd.
Euroseas Ltd. was formed on May 5, 2005 under the laws of the Republic of the Marshall Islands to consolidate the ship owning interests of the Pittas family of Athens, Greece, which has been in the shipping business over the past 140 years. Euroseas trades on the NASDAQ Capital Market under the ticker ESEA.

Euroseas operates in the container shipping market. Euroseas’ operations are managed by Eurobulk Ltd., an ISO 9001:2008 and ISO 14001:2004 certified affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. Euroseas employs its vessels on spot and period charters and through pool arrangements. 

The Company has a fleet of 18 vessels, including 10 Feeder and 8 Intermediate containerships with a cargo capacity of 58,871 teu. After the delivery of seven feeder containership newbuildings in 2023 and the first half of 2024, Euroseas’ fleet will consist of 25 vessels with a total carrying capacity of 75,471 teu.

Forward Looking Statement
This press release contains forward-looking statements (as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended) concerning future events and the Company’s growth strategy and measures to implement such strategy; including expected vessel acquisitions and entering into further time charters. Words such as “expects,” “intends,” “plans,” “believes,” “anticipates,” “hopes,” “estimates,” and variations of such words and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct. These statements involve known and unknown risks and are based upon a number of assumptions and estimates that are inherently subject to significant uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to changes in the demand for containerships, competitive factors in the market in which the Company operates; risks associated with operations outside the United States; and other factors listed from time to time in the Company’s filings with the Securities and Exchange Commission. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based. 

Visit our website www.euroseas.gr

Company Contact

Investor Relations / Financial Media

Tasos Aslidis
Chief Financial Officer
Euroseas Ltd.
11 Canterbury Lane,
Watchung, NJ 07069
Tel. (908) 301-9091
E-mail: 
aha@euroseas.gr

Nicolas Bornozis
Markella Kara
Capital Link, Inc.
230 Park Avenue, Suite 1540
New York, NY 10169
Tel. (212) 661-7566
E-mail: 
euroseas@capitallink.com

 

Release – ACCO Brands’ Graciela Monteagudo Recognized as NACD Directorship 100 Honoree



ACCO Brands’ Graciela Monteagudo Recognized as NACD Directorship 100™ Honoree

Research, News, and Market Data on ACCO Brands

The 16th Annual NACD Directorship 100™ List Recognizes the Most
Influential Corporate Directors and Governance Experts

LAKE ZURICH, Ill.–(BUSINESS WIRE)– The National Association of Corporate Directors (NACD) announced the 2022 NACD Directorship 100™—the most influential peer-nominated leaders in the boardroom and corporate governance community. Included among this year’s esteemed honorees is Graciela Monteagudo of ACCO Brands.

“We applaud Graciela for this deserved recognition,” said Boris Elisman, Chairman and Chief Executive Officer, ACCO Brands. “It is a testament to Graciela’s expertise that other directors put forward her nomination. As the Chair of the Nominating, Governance and Sustainability Committee, she leads our Board’s deliberations on governance and ESG topics, and champions improvements in policies and disclosure. We are very proud that Graciela is a 2022 NACD honoree.”

Now in its 16th year, the NACD Directorship 100 awards recognize peer-nominated leading directors and governance professionals. Honorees are evaluated in four key categories: integrity, mature confidence, informed judgment and high-performance standards. A selection committee reviewed the nominees’ histories of advancing board performance and leading corporate governance practices in accordance with established NACD principles. The principles are a framework that encourages excellence in areas that include risk oversight, corporate strategy, compensation and transparency.

“The NACD Directorship 100 continues to honor those who have demonstrated exemplary board leadership and innovation in corporate governance,” said Peter R. Gleason, NACD President and Chief Executive Officer. “We honor these individuals’ forward-thinking minds and their ability to lead their boards and organizations to current and future success.”

The complete list of the 2022 NACD Directorship 100 is available at https://directorship100.nacdonline.org/honorees/2022.

Honorees will be recognized during the NACD Directorship 100 Gala, a black-tie event being held on June 22 at Cipriani 42nd Street in New York City. To learn more about the NACD Directorship 100 Gala, please visit the Directorship 100 Gala and sponsorship site.

About ACCO Brands Corporation

ACCO Brands Corporation (NYSE: ACCO) is one of the world’s largest designers, marketers and manufacturers of branded academic, consumer and business products. Our widely recognized brands include Artline®, AT-A-GLANCE®, Barrilito®, Derwent®, Esselte®, Five Star®, Foroni®, GBC®, Hilroy®, Kensington®, Leitz®, Mead®, PowerA®, Quartet®, Rapid®, Rexel®, Swingline®, Tilibra®, Wilson Jones® and many others. Our products are sold in more than 100 countries around the world. More information about ACCO Brands, the Home of Great Brands Built by Great People, can be found at www.accobrands.com.

About NACD

For more than 40 years, NACD has been on the leading edge of corporate governance, setting standards of excellence that have elevated board performance. NACD arms today’s directors with insights and education that drive their mission forward, while preparing a new generation of boardroom leaders to meet tomorrow’s biggest challenges. NACD is a community of more than 23,000 directors driven by a common purpose: to be trusted catalysts of economic opportunity and positive change—in businesses and in the communities they serve. To learn more about NACD, visit nacdonline.org.

View source version on businesswire.comhttps://www.businesswire.com/news/home/20220503005778/en/

Julie McEwan
julie.mcewan@acco.com
(937) 974-8162

Shannon Bernauer
sbernauer@nacdonline.org
(571) 367-3688

Source: ACCO Brands Corporation

SEC Announces Crypto Assets and Cyber Unit Will Double in Size


Image Credit: Richard Patterson (Flickr)


SEC Nearly Doubles Size of Enforcement’s Crypto Assets and Cyber Unit

The Securities and Exchange Commission (SEC) just announced (May 3) that an additional 20 positions will be added to the unit responsible for protecting investors in crypto markets and from cyber-related threats. The newly renamed Crypto Assets and Cyber Unit (formerly known as the Cyber Unit) in the Division of Enforcement will expand to 50 staff members dedicated to the unit.

SEC Chairman Gary Gensler, who once taught blockchain and crypto at MIT, says the crypto industry is rife with fraud and abuse. He likens it to the “Wild West.”

“The U.S. has the greatest capital markets because investors have faith in them, and as more investors access the crypto markets, it is increasingly important to dedicate more resources to protecting them,” said Chairman Gensler. “The Division of Enforcement’s Crypto Assets and Cyber Unit has successfully brought dozens of cases against those seeking to take advantage of investors in crypto markets.

By nearly doubling the size of this key unit, the SEC expects to be better equipped to police wrongdoing in the cryptocurrency markets while continuing to identify disclosure and controls issues surrounding cybersecurity.” Since its creation in 2017, the unit has brought more than 80 enforcement actions related to fraudulent and unregistered crypto-asset offerings and platforms. This has resulted in monetary relief totaling more than $2 billion.

The expanded Crypto Assets and Cyber Unit will leverage the agency’s expertise to ensure investors are protected in the crypto markets, with a focus on investigating securities law violations related to:

  • Crypto asset offerings
  • Crypto asset exchanges
  • Crypto asset lending and staking products
  • Decentralized finance (“DeFi”) platforms
  • Non-fungible tokens (“NFTs”)
  • Stablecoins

In addition, the unit has brought actions against SEC registrants and public companies for failing to maintain adequate cybersecurity controls and for failing to appropriately disclose cyber-related risks and incidents.

The Crypto Assets and Cyber Unit will continue to tackle cyber-related threats to U.S. markets. “Crypto markets have exploded in recent years, with retail investors bearing the brunt of abuses in this space. Meanwhile, cyber-related threats continue to pose existential risks to our financial markets and participants,” said Gurbir S. Grewal, Director of the SEC’s Division of Enforcement. “The bolstered Crypto Assets and Cyber Unit will be at the forefront of protecting investors and ensuring fair and orderly markets in the face of these critical challenges.” The expansion by 20 additional positions into the Crypto Assets and Cyber Unit will bolster the ranks of its supervisors, investigative staff attorneys, trial counsels, and fraud analysts in the agency’s headquarters in Washington, DC, as well as several regional offices.

Paul Hoffman

Managing Editor, Channelchek

Suggested Reading



Cryptocurrencies in 2022, a View from Academics



The SEC Wants to Extend Investor Protections to Crypto Platforms





Metaverse: Is The Future Real? – Panel Presentation from NobleCon18



The World Is HOT Right Now! – Panel Presentation from NobleCon18

Source

https://www.sec.gov/news/press-release/2022-78

 

Stay up to date. Follow us:

 

Will Investors Get What they are Looking for From the Fed?


Image Credit: Marco Verch (Flickr)


Will Investors Rework their Positions in Response to Fed Statements?

Will the Fed send any new signals after its May FOMC meeting?

Federal Reserve members have set investor expectations for a 50bp increase in overnight rates after the May 4 meeting. It’s a pretty safe bet. Anything different would severely spook the markets. However, where the surprise may come is in what Chairman Jay Powell says related to the future after the two-day meeting. This could adjust expectations which would cause investors to adjust their portfolios.

A New Wrinkle to Watch

 While the markets believe that at the following meeting in June the FOMC will also serve up a 50bp hike, last week’s negative first-quarter GDP report may cause the Chairman to speak more cautiously.  And no one has clarity on what the Fed may do after June. One new wrinkle Fed-watchers are aware of is that the negative Q1 GDP, by definition, places us halfway to a recession. If the current quarter also shows negative growth, we are, by definition, already in a recession.

Tightening monetary policy to stop inflation while the economy is shrinking is stagflation.

Investors will be placing every word in the Fed Chairman’s post-meeting statement under a microscope. Inflation is still running at 40-year highs. Interest rates are well below inflation rates creating negative real yields (interest rate minus inflation). Investors prefer to earn above future inflation expectations.

So what are the Fed’s expectations? We should know tomorrow afternoon.


Current Market Expectations

The half a percentage point increase expected is considered aggressive. The Fed typically acts in 25 bp moves and then measures the results. Fed Funds are currently targeted at 0.25%-0.50%, so doubling the level truly is unusual. Many economists, based on previous Fed-speak, expect that a similar move will be made in June before the policymakers sit back and let the market absorb their moves.

The Fed has a number of accommodative stances in place that it discussed unwinding beginning this year – market participants want to know if anything has changed. One of them is to begin shrinking its $9 trillion asset portfolio, starting in the first half and at a much faster pace than its sidetracked attempt at passively reducing its holdings went five years ago.

Since Last Tightening

In March, Fed officials lifted their benchmark federal-funds rate to a range between 0.25% and 0.50%, from near zero. They also projected they could lower inflation back to their 2% target without raising the fed-funds rate higher than 3%. They have considered 2% their neutral range where the economy would avoid getting too heated and avoid slumping.

Economic reports released since the Fed’s last 2022 meeting suggest price pressures could remain more persistent as employers continue to give in to higher wage pressures along with price inputs. On Friday, a Labor Department measure of worker pay that is closely watched by central-bank officials showed wages and benefits for private-sector workers continued to rise at its highest rate since 2000.

Fed communication with the public is especially important now because the central bank is relying on market expectations about its future policy intentions to play a major role in removing stimulus without undue costs to the economy.

Take-Away

Bond traders who watch the Fed most closely are expecting a 50bp increase. Not 25bp and not 75bp. The Fed would disrupt the market if they did anything different. It’s future expectations that will be managed both for the overnight lending rate and the more entrenched stimulus that has been in the system as the Fed purchased longer-term bonds. “Mopping” up this stimulus, which has had a very positive impact on economic growth, is tricky.

Chairman Powell’s audience will be listening intently to know what the future holds. In reality, not even the Fed Chair himself knows what is coming in the next year or two. But, the market will at least hear what the top banker is expecting. 

The FOMC announcement should come at 2pm on May 4.

Paul Hoffman

Managing Editor, Channelchek

Suggested Reading



Has the Fed Run Out of Good Options?



Deflation Not Inflation is Risk Says Cathie Wood





What is the Yield Curve?



What is the Fed’s Beige Book?

Sources

https://www.federalreserve.gov/monetarypolicy/fomccalendars.htm

https://www.usnews.com/news/business/articles/2022-05-03/asian-shares-mixed-in-light-golden-week-trading

https://www.wsj.com/articles/feds-message-on-interest-rate-path-destination-will-be-scrutinized-11651570200?mod=hp_lead_pos4

 

Stay up to date. Follow us:

 

Release – RG6501 (OpRegen) Phase 1/2a Clinical Results Support the Potential for OpRegen to Slow, Stop or Reverse Disease Progression in Geographic Atrophy Secondary to Age-Related Macular Degeneration

 



RG6501 (OpRegen®) Phase 1/2a Clinical Results Support the Potential for OpRegen to Slow, Stop or Reverse Disease Progression in Geographic Atrophy Secondary to Age-Related Macular Degeneration

Research, News, and Market Data on Lineage Cell Therapeutics

  • 12-Month Primary
    Endpoint Data Suggest OpRegen is Well Tolerated with an Acceptable Safety
    Profile
  • Preliminary
    Evidence of Visual Function and Outer Retinal Structure Improvements
    Observed in Cohort 4 Patients with GA and Impaired Vision
  • Data Reported at
    2022 ARVO Meeting by Allen C. Ho, M.D., FACS

CARLSBAD, Calif.–()–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that results from the primary endpoint, safety and tolerability 1 year post-transplant, in the ongoing Phase 1/2a clinical study of RG6501 (OpRegen), a retinal pigment epithelial cell therapy currently in development for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD), were presented yesterday at the 2022 Association for Research in Vision and Ophthalmology
Annual Meeting
 (ARVO 2022). The presentation, “Safety and Efficacy of a Phase 1/2a Clinical Trial of Transplanted
Allogeneic Retinal Pigmented Epithelium (RPE, OpRegen) Cells in Advanced Dry
Age-Related Macular Degeneration (AMD)”
 was featured as part of the Retinal Prostheses and Transplantation Session, by Allen C. Ho, M.D., FACS, Wills Eye Hospital Attending Surgeon and Director of Retina Research, Professor of Ophthalmology, Thomas Jefferson University, Mid Atlantic Retina and President, The Retina Society (abstract number 3714956). RG6501 (OpRegen) is currently being developed under an exclusive worldwide collaboration between Lineage, Roche and Genentech, a member of the Roche Group.

“These data, though uncontrolled, offer the promising demonstration that OpRegen may be able to impact GA disease progression in a clinically meaningful manner, particularly when delivered on-target and in earlier disease, in patients afflicted with what was previously thought to be an inevitably progressive disease,” stated Dr. Ho. “Obviously, larger, controlled studies are required, but spontaneous disease regression does not occur in GA so these results suggest that OpRegen may be a potentially transformational therapy and strongly support further development.”

2022 ARVO Presentation
Highlights

Summary of Safety Results

  • All 24 treated patients reported at least one adverse event (AE) and at least one ocular AE
  • The majority of AEs reported with OpRegen were mild (Cohort 1-3, 87%; Cohort 4, 93%), and the immunosuppressive regimen was well tolerated
  • Ocular AEs observed with OpRegen were mainly related to the surgical procedures used for subretinal delivery, with the most common being conjunctival hemorrhage/hyperemia (n=17) and epiretinal membrane (n=16)
  • One patient discontinued the study due to an AE that was unrelated to treatment
  • No cases of rejection, acute or delayed intraocular inflammation, or sustained increases in intraocular pressure following OpRegen subretinal delivery have been reported

Summary of Activity Results

  • Preliminary evidence of improvement in visual function was observed in patients with GA and impaired vision at baseline (Cohort 4 [n=12])
    • Patients in Cohort 4 had an average 7.6 letter gain in visual acuity at 12 months in the study eye
    • Three patients in Cohort 4 (25%) had a 15 letter or greater gain in visual acuity at 12 months in the study eye
  • Five patients in Cohort 4 with OpRegen delivered to most or all of the GA area, including the fovea, had greater gains in visual function (average 12.8 letter gain), with evidence for regions of apparent improvement of outer retinal structure as assessed by SD-OCT
    • The SD-OCT imaging analysis is ongoing

These data support the potential for OpRegen to slow, stop or reverse disease progression in GA. Further assessment of the optimal disease stage for intervention, surgical procedure for subretinal delivery and target delivery location of OpRegen in a larger, controlled clinical study is needed to confirm these findings.

Dr. Ho’s presentation is available on the Events and Presentations section of Lineage’s website.

The Association for Research in Vision and Ophthalmology, Inc. (ARVO) was founded in 1928 in Washington, DC by a group of 73 ophthalmologists. ARVO is the largest and most respected eye and vision research organization in the world. ARVO members include nearly 11,000 researchers from over 75 countries. ARVO advances research worldwide into understanding the visual system and preventing, treating and curing its disorders. For more information, please visit https://www.arvo.org/ or follow the association on Twitter @ARVOInfo.

About OpRegen

OpRegen® is a retinal pigment epithelial cell therapy in development for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration. Following subretinal delivery, OpRegen has the potential to counteract RPE cell loss in areas of GA lesions by supporting retinal structure and function. OpRegen is being developed under a worldwide collaboration between Lineage, Roche and Genentech, a member of the Roche Group.

About the Phase 1/2a Study

The Phase 1/2a study is an open-label, single-arm, multi-center, dose-escalation trial evaluating a single administration of OpRegen delivered subretinally in patients with bilateral GA. Twenty-four patients were enrolled into 4 cohorts. The first 3 cohorts enrolled only legally blind patients with a best corrected visual acuity (BCVA) of 20/200 or worse. The fourth cohort enrolled 12 patients with impaired vision (BCVA from 20/65 to 20/250 with smaller mean areas of GA). Cohort 4 also included patients treated with a new “thaw-and-inject” formulation of OpRegen, which can be shipped directly to sites and used immediately upon thawing, removing the complications and logistics of having to use a dose preparation facility. The primary objective of the study was to evaluate the safety and tolerability of OpRegen as assessed by the incidence and frequency of treatment-emergent adverse events. Secondary objectives are to evaluate the preliminary activity of OpRegen treatment by assessing the changes in ophthalmological parameters measured by various methods of primary clinical relevance.

About Geographic Atrophy

Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) characterized by severe loss of visual function. GA is a leading cause of adult blindness in the developed world, affecting at least 5 million people globally. There are two forms of advanced AMD: neovascular AMD and GA. GA and neovascular AMD can occur simultaneously in the same eye, and patients treated for neovascular AMD may still go on to develop GA. GA typically affects both eyes. There are currently no U.S. Food and Drug Administration (FDA) or European Medicines Agency (EMA) approved treatment options available for patients with GA.

About Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Lineage’s clinical programs are in markets with billion dollar opportunities and include five allogeneic (“off-the-shelf”) product candidates: (i) OpRegen, a retinal pigment epithelial cell therapy in Phase 1/2a development for the treatment of geographic atrophy secondary to age-related macular degeneration; (ii) OPC1, an oligodendrocyte progenitor cell therapy in Phase 1/2a development for the treatment of acute spinal cord injuries; (iii) VAC2, a dendritic cell therapy produced from Lineage’s VAC technology platform for immuno-oncology and infectious disease, currently in Phase 1 clinical development for the treatment of non-small cell lung cancer (iv) ANP1, an auditory neuronal progenitor cell therapy for the potential treatment of auditory neuropathy, and (v) PNC1, a photoreceptor neural cell therapy for the treatment of vision loss due to photoreceptor dysfunction or damage. For more information, please visit www.lineagecell.com or follow the company on Twitter @LineageCell.

Forward-Looking Statements

Lineage cautions you that all statements, other than statements of historical facts, contained in this press release, are forward-looking statements. Forward-looking statements, in some cases, can be identified by terms such as “believe,” “aim,” “may,” “will,” “estimate,” “continue,” “anticipate,” “design,” “intend,” “expect,” “could,” “can,” “plan,” “potential,” “predict,” “seek,” “should,” “would,” “contemplate,” “project,” “target,” “tend to,” or the negative version of these words and similar expressions. Such statements include, but are not limited to, statements relating to the collaboration and license agreement with Roche and Genentech and activities expected to occur thereunder; and the potential benefits of treatment with OpRegen and that OpRegen may be a potential transformational therapy. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Lineage’s actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by the forward-looking statements in this press release, including, but not limited to, the risk that positive findings in early clinical and/or nonclinical studies of a product candidate may not be predictive of success in subsequent clinical and/or nonclinical studies of that candidate; the risk that competing alternative therapies may adversely impact the commercial potential of OpRegen; the risk that Roche and Genentech may not be successful in completing further clinical trials for OpRegen and/or obtaining regulatory approval for OpRegen in any particular jurisdiction; the risk that Lineage may not be able to manufacture sufficient clinical quantities of its product candidates in accordance with current good manufacturing practice; risks and uncertainties inherent in Lineage’s business and other risks discussed in Lineage’s filings with the Securities and Exchange Commission (SEC). Lineage’s forward-looking statements are based upon its current expectations and involve assumptions that may never materialize or may prove to be incorrect. All forward-looking statements are expressly qualified in their entirety by these cautionary statements. Further information regarding these and other risks is included under the heading “Risk Factors” in Lineage’s periodic reports with the SEC, including Lineage’s most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q filed with the SEC and its other reports, which are available from the SEC’s website. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they were made. Lineage undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.

Contacts

Lineage Cell Therapeutics, Inc. IR
Ioana C. Hone
(
ir@lineagecell.com)
(442) 287-8963

Solebury Trout IR
Mike Biega
(
Mbiega@soleburytrout.com)
(617) 221-9660

Russo Partners – Media Relations
Nic Johnson or David Schull
Nic.johnson@russopartnersllc.com
David.schull@russopartnersllc.com
(212) 845-4242

Release – Comstock Announces First Quarter 2022 Results



Comstock Announces First Quarter 2022 Results

Research, News, and Market Data on Comstock Mining

VIRGINIA CITY, Nevada, May 03, 2022 (GLOBE NEWSWIRE) — Comstock Mining Inc. (NYSE: LODE) (“Comstock” and the “Company”) today announced its recent operational highlights, first quarter 2022 results, and updated outlook.

Selected Strategic
Highlights – Cellulosic Fuels

  • Demonstrated breakthrough renewable Bioleum™ alternative to fossil crude oil, derived from from woody biomass, for use in producing renewable diesel, sustainable aviation, gasoline, marine and other drop-in carbon-neutral fuels.
  • Established our near-term goal to commission our first 100 million gallon Bioleum™ biorefinery by 2025.
  • Commenced construction on a demonstration facility for production of Bioleum™ and other co-products.
  • Commenced site evaluation and selection process, prioritizing target sites with ready access to available feedstock.
  • Commenced direct discussions for renewable fuel offtake agreements to support our first biorefinery and beyond.

Selected Strategic Highlights
– Lithium Extraction and Electrification Products

  • Received and installed proprietary lithium-ion battery (“LIB”) crushing, separation, and conditioning systems and commenced commissioning in our R&D facility.
  • On schedule to be producing marketable black mass from LIB feedstock in our state-of-the-art, battery metal recycling facility in Nevada by the end of Q4 2022.
  • On schedule to be producing marketable, battery-grade lithium carbonate in our state-of-the-art, battery metal recycling facility in Nevada by the end of Q2 2023.
  • Commenced construction of prototype “lithium first” extraction system in our R&D facility.
  • Commenced new and continued ongoing discussions with LIB feedstock sources.

Selected Financial
Results

  • Advanced non-strategic asset monetization, exchanging $6.65 million note receivable for the Lucerne properties and an option for $7.75 million. Our announced transactions for a portion of our non-strategic mineral and other assets now total over $25 million of expected 2022 proceeds from Tonogold, Sierra Springs and others.
  • Total assets increased to $115,119,393 as of March 31, 2022, as compared to $43,123,562 at December 31, 2020.
  • Operating expenses were $4,442,713 for the first quarter 2022, including selling, general and administrative expenses of $2,402,766 and research and development expenses of $1,195,418, as compared to operating expenses of $3,621,695 for the fourth quarter of 2021, with increases primarily relating to increased research and development, employment costs and depreciation.
  • First quarter 2022 net loss was $6,547,023 or $(0.09) per share, as compared to first quarter 2022 net income of $8,188,231 or $0.22 per share. The 2021 results were primarily driven by changes in fair values of derivatives.
  • Debt was $4,529,068 on March 31, 2022, representing an unsecured promissory note.
  • Cash and cash equivalents were $2,249,007 on March 31, 2022.
  • Outstanding common shares were 67,707,832 at March 31, 2022, and 69,943,776 at April 28, 2022.

“Our financial results reflect the impact of our continued investment in the development and commercialization of our renewable energy businesses,” said Corrado De Gasperis, Comstock’s executive chairman and chief executive officer. “Our Cellulosic Fuels and Battery Recycling demonstration systems are moving us rapidly towards commercialization. We are engaged in and securing untapped supplies of carbon neutral feedstocks to enable exponential and sustained growth.”

The Company expects to complete the demonstration of our breakthrough LIB crushing, separating, and conditioning process in the second quarter of this year, to successfully confirm LIB processing without discharge and the production of highly concentrated “black mass” powders. The Company expects to complete the submission of all expanded and modified operating permits for our LIB processes at our state-of-the-art, battery metal recycling facility in Nevada in the second quarter.

The Company is currently expanding its existing cellulosic demonstration systems in Wisconsin to include the production of Bioleum™ and expects these demonstration systems will be operational before the end of the fiscal year. The Company expects to release more detailed information about Bioleum™ and its planned biorefineries later this month at the Company’s Annual Meeting of Shareholders on May 26, 2022, at the Atlantis Hotel in Reno, Nevada.

The Company expects $15 million in proceeds over the next two quarters from the sale of its industrial and commercial properties. The Company is exploring options to monetize all non-strategic assets, with updates in the second and third quarters.

Conference Call Details

Comstock will host the conference call on Tuesday, May 3, 2022, at 8:00 a.m. PDT (11:00 a.m. EDT) and the webcast will include a moderated question and answer session following the Company’s prepared remarks.  Please click the link below to register in advance and please join the event at least 10 minutes prior to the scheduled start time. Once registered, you will receive a confirmation email containing information about joining the Webcast. Please click here to register in advance for this webcast.

About Comstock

Comstock (NYSE: LODE) innovates technologies that contribute to global decarbonization and circularity by efficiently converting under-utilized natural resources into renewable fuels and electrification products that contribute to balancing global uses and emissions of carbon. The Company intends to achieve exponential growth and extraordinary financial, natural, and social gains by building, owning, and operating a fleet of advanced carbon neutral extraction and refining facilities, by selling an array of complimentary process solutions and related services, and by licensing selected technologies to qualified strategic partners. To learn more, please visit www.comstock.inc.

Forward-Looking
Statements 

This press release and any related calls or discussions may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, are forward-looking statements. The words “believe,” “expect,” “anticipate,” “estimate,” “project,” “plan,” “should,” “intend,” “may,” “will,” “would,” “potential” and similar expressions identify forward-looking statements, but are not the exclusive means of doing so. Forward-looking statements include statements about matters such as: future industry market conditions; future explorations or acquisitions; future changes in our exploration activities; future changes in our research and development; and future prices and sales of, and demand for, our products and services. Except as may be required by securities or other law, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Neither this press release nor any related call or discussion constitutes an offer to sell, the solicitation of an offer to buy or a recommendation with respect to any securities of the Company, the fund or any other issuer.

Contact information:

 

 

Comstock Mining Inc.
P.O. Box 1118
Virginia City, NV 89440
www.comstock.inc

Corrado De Gasperis
Executive Chairman & CEO
Tel (775) 847-4755
degasperis@comstockmining.com

Zach Spencer
Director of External Relations
Tel (775) 847-5272 Ext.151
questions@comstockmining.com

Release – Sierra Metals Subsidiary in Peru, Sociedad Minera Corona Reports Q1-2022 Financial Results



Sierra Metals Subsidiary in Peru, Sociedad Minera Corona Reports Q1-2022 Financial Results

Research, News, and Market Data on Sierra Metals

TORONTO–()–Sierra Metals Inc. (TSX: SMT) (BVL: SMT) (NYSE AMERICAN: SMTS) (“Sierra Metals” or “the Company”) announces the filing of Sociedad Minera Corona S.A.’s (“Corona”) unaudited Financial Statements and the Management Discussion and Analysis (“MD&A”) for the first quarter of 2022 (“Q1 2022”).

 

The Company holds an 81.8% interest in Corona. All amounts are presented in US dollars unless otherwise stated and have not been adjusted for the 18.2% non-controlling interest.

Corona’s Q1-2022 financial statements have not been reviewed by the Sierra Metals Board. The Company will be releasing its Q1-2022 consolidated financial statements on May 11th, 2022 with an investor conference call taking place on May 12th, 2022.

Corona’s Highlights for the
Three Months Ended March 31, 2022

  • Revenues of US$35.8 million, a 15%
    decrease from Q1 2021.
  • Adjusted EBITDA of US$14.8 million, an
    8% decrease from Q1 2021.
  • Total tonnes processed of 315,250, a
    3% decrease from Q1 2021.
  • Net production revenue per tonne of
    ore milled decreased by 5% to US$121.34.
  • Cash Cost per copper equivalent
    payable pound higher by 48% to US$2.19.
  • All-in sustaining cost
    (“AISC”) per copper equivalent payable pound higher by 40% to
    US$3.70.
  • Copper equivalent pounds production
    decreased 32% to 10.9 million pounds.
  • $17.0 million of cash and cash
    equivalents as at March 31, 2022.
  • $70.3 million of working capital as at
    March 31, 2022.

The Yauricocha mine processed 315,250 tons during the Q1 2022, which represents a decrease of 3% compared Q1 2021. Labor shortages were experienced in development and mining areas due to the impact of COVID-19 in January and February.

The delays in preparation of the polymetallic mining zones forced the mine to focus on copper sulfides during the quarter, which resulted in higher copper head grades, but negatively impacted grades for all other metals, except gold. Q1 2022 copper and gold production was 60% and 19% higher, while silver, lead and zinc production were 43%, 56% and 57% lower respectively as compared to Q1 2021. Copper equivalent production for Q1 2022 from Yauricocha was 10,876 pounds or 32% lower than the same quarter of 2021. This reflects the decrease in average ore grade on current permitted mining areas.

Luis Marchese, CEO of Sierra Metals, commented, “During Q1 2022, 
Yauricocha metal production was negatively impacted due to
decreasing ore grades in the currently permitted mining areas, and Covid
related labour shortages in the early part of the year.”

He continued, “Looking ahead, our priority is to
treat ore at full plant capacity and incorporate the newly discovered
high-grade areas in order to maximize metal production at current prices.”

He concluded, “We expect that we will be able to
make up for the delay in production at Yauricocha, and with improved grades, we
are optimistic about our progress in the Mine’s performance going forward.”

The following table displays selected unaudited financial information for the three months ended March 31, 2022:

Press Release
Selected Financial Results

 

 

 

(In thousands
of US dollars, except cash cost and revenue

Three Months Ended

per tonne
metrics)

March 31, 2022

March 31, 2021

Var %

 

Revenue

$

35,794

41,925

-15%

Adjusted EBITDA (1)

14,803

16,173

-8%

Cash Flow from operations

11,080

16,496

-33%

Gross profit

13,268

16,149

-18%

Income Tax Expense

1,268

(6,842)

-119%

Net Income

10,497

5,175

103%

 

Net production revenue per tonne of ore milled 
(2)

121.34

128.10

-5%

Cash cost per tonne of ore milled (2)

59.19

60.43

-2%

 

Cash cost per copper equivalent payable pound 
(2)

2.19

1.48

48%

All-In Sustaining Cost per copper equivalent payable pound (2)

3.70

2.65

40%

 

(In thousands of US dollars, unless
otherwise stated)

March 31, 2022

December 31,
2021

 

Cash and cash equivalents

$

17,041

32,870

Assets

235,267

232,868

Liabilities

58,013

66,111

Equity

177,254

166,757

 

(1)

 

 

 

Adjusted EBITDA
includes adjustments for depletion and depreciation, interest expense and
other financing costs, interest income, share-based compensation, Foreign
Exchange (gain) loss and income taxes; see non-IFRS Performance Measures
section of the Company’s MD&A.

(2)

 

 

 

Net production
revenue per tonne, cash cost per tonne, cash cost per copper equivalent
payable pound and All-In Sustaining Cost per copper (‘AISC’) equivalent pound
are non-IFRS performance measures. AISC includes the cost of sales, treatment
and refining charges, sustaining capital expenditures, general and
administrative expense, and selling expense, and exclude workers’ profit
sharing, depreciation, and other non-cash provisions; see non-IFRS
Performance Measures section of the Company’s MD&A.

The following table displays average realized metal prices information for the quarter ended March 31, 2022 vs March 31, 2021:

Average realized prices

Quarter ended March 31

Increase

In US$

2022

2021

(%)

Silver ($/oz)

23.95

26.44

-9%

Copper ($/lb)

4.53

3.88

17%

Zinc ($/lb)

1.69

1.24

36%

Lead ($/lb)

1.06

0.92

15%

Gold ($/oz)

1,875

1,778

5%

Corona’s Financial Highlights
for the Three Months Ended March 31, 2022

  • Revenue from metals payable at the Yauricocha Mine in Peru of $35.8 million for Q1 2022 decreased by 15% compared to $41.9 million of revenues in Q1 2021. Despite higher metal prices, revenues decreased during Q1 2022 mainly due to lower metal production attributable to lower grades except copper. Copper equivalent payable pounds dropped 51% due to lower quantities of metals sold as compared to Q1 2021.
  • Yauricocha’s cash cost per copper equivalent payable pound was $2.19 (Q1 2021 – $1.48), and AISC per copper equivalent payable pound of $3.70 (Q1 2021 – $2.65). Higher unit costs resulted from a 36% decrease in copper equivalent payable pounds.
  • Adjusted EBITDA of US$14.8 million for the first quarter of 2022 compared to US$16.2 million for the same period of 2021. The decrease in Adjusted EBITDA for the first quarter of 2022 compared to the same period of the year 2021 was due to lower revenues from the Company, explained above.
  • Operating cash flow before movements in working capital of US$11.1 million for the first quarter of 2022 compared to US$16.5 million in the same period of 2021.
  • Cash and cash equivalents of $17.0 million as at March 31, 2022, compared to $32.9 million as at December 31, 2021. Cash and cash equivalents decreased as cash used in investing activities ($6.2 million) and financing activities ($10.5 million) exceeded cash flow of $0.8 million generated from operating activities.
  • Net income of $10.5 million, or $0.292 per share for Q1 2022 compared to net income of $5.2 million, or $0.144 per share for Q1 2021. The increase in net income during Q1 2022 resulted from the recovery of deferred taxes and no current taxes as there was no taxable income during the quarter.

Corona’s Operational
Highlights for the Three Months Ended March 31, 2022:

The following table displays the production results for the three months ended March 31, 2022:

Yauricocha
Production

Three Months Ended March 31,

2022

2021

% Var.

 

Tonnes processed

315,250

326,211

-3%

Daily throughput

3,603

3,728

-3%

 

 

Silver grade (g/t)

39.40

54.35

-28%

Copper grade

0.79%

0.56%

41%

Lead grade

0.66%

1.34%

-51%

Zinc grade

1.83%

3.71%

-51%

Gold Grade (g/t)

0.52

0.43

21%

 

Silver recovery

63.99%

79.05%

-19%

Copper recovery

77.22%

66.26%

17%

Lead recovery

82.50%

90.16%

-8%

Zinc recovery

82.09%

90.34%

-9%

Gold Recovery

20.06%

19.77%

1%

 

 

Silver production (000 oz)

256

451

-43%

Copper production (000 lb)

4,279

2,682

60%

Lead production (000 lb)

3,828

8,706

-56%

Zinc production (000 lb)

10,492

24,123

-57%

Gold Production (oz)

1,057

890

19%

 

 

Copper equivalent pounds (000’s)(1)

10,876

15,937

-32%

 

(1)

 

 

 

Copper
equivalent pounds for Q1 2022 were calculated using the following realized
prices: $23.95/oz Ag, $4.53/lb Cu, $1.69/lb Zn, $1.06/lb Pb, $1,875/oz Au.
Copper equivalent pounds for Q1 2021 were calculated using the following
realized prices: $26.44/oz Ag, $3.88/lb Cu, $1.24/lb Zn, $0.92/lb Pb,
$1,778/oz Au.

Quality Control

Américo Zuzunaga, FAusIMM CP (Mining Engineer) and Vice President of Corporate Planning, is a Qualified Person under National Instrument 43-101 – Standards of Disclosure for Mineral Projects.

About Sierra Metals

Sierra Metals Inc. is a diversified Canadian mining company with Green Metal exposure including increasing copper production and base metal production with precious metals byproduct credits, focused on the production and development of its Yauricocha Mine in Peru, and Bolivar and Cusi Mines in Mexico. The Company is focused on increasing production volume and growing mineral resources. Sierra Metals has recently had several new key discoveries and still has many more exciting brownfield exploration opportunities at all three Mines in Peru and Mexico that are within close proximity to the existing mines. Additionally, the Company also has large land packages at all three mines with several prospective regional targets providing longer-term exploration upside and mineral resource growth potential.

The Company’s Common Shares trade on the Toronto Stock Exchange and the Bolsa de Valores de Lima under the symbol “SMT” and on the NYSE American Exchange under the symbol “SMTS”.

Continue to Follow, Like and Watch our progress:

Webwww.sierrametals.com | Twittersierrametals | FacebookSierraMetalsInc |
LinkedInSierra Metals Inc | Instagramsierrametals

Forward-Looking Statements

This press release contains “forward-looking information” and “forward-looking statements” within the meaning of Canadian and U.S. securities laws (collectively, “forward-looking information”). Forward-looking information includes, but is not limited to, statements with respect to the date of the 2020 Shareholders’ Meeting and the anticipated filing of the Compensation Disclosure. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as “expects”, “anticipates”, “plans”, “projects”, “estimates”, “assumes”, “intends”, “strategy”, “goals”, “objectives”, “potential” or variations thereof, or stating that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative of any of these terms and similar expressions) are not statements of historical fact and may be forward-looking information.

Forward-looking information is subject to a variety of risks and uncertainties, which could cause actual events or results to differ from those reflected in the forward-looking information, including, without limitation, the risks described under the heading “Risk Factors” in the Company’s annual information form dated March 16, 2022 for its fiscal year ended December 31, 2021 and other risks identified in the Company’s filings with Canadian securities regulators and the United States Securities and Exchange Commission, which filings are available at www.sedar.com and www.sec.gov, respectively.

The risk factors referred to above are not an exhaustive list of the factors that may affect any of the Company’s forward-looking information. Forward-looking information includes statements about the future and is inherently uncertain, and the Company’s actual achievements or other future events or conditions may differ materially from those reflected in the forward-looking information due to a variety of risks, uncertainties and other factors. The Company’s statements containing forward-looking information are based on the beliefs, expectations, and opinions of management on the date the statements are made, and the Company does not assume any obligation to update such forward-looking information if circumstances or management’s beliefs, expectations or opinions should change, other than as required by applicable law. For the reasons set forth above, one should not place undue reliance on forward-looking information.

Contacts

For further information regarding Sierra Metals, please visit www.sierrametals.com

Investor Relations
CEO

Sierra Metals Inc.
Tel: +1 (416) 366-7777
Email: 
info@sierrametals.com

Luis Marchese
Sierra Metals Inc.
Tel: +1 (416) 366-7777

TAAL Distributed Information Technologies (TAALF) – Reports 4Q21 Results

Tuesday, May 03, 2022

TAAL Distributed Information Technologies (TAALF)
Reports 4Q21 Results

TAAL Distributed Information Technologies Inc. delivers value-added blockchain services, providing professional-grade, highly scalable blockchain infrastructure and transactional platforms to support businesses building solutions and applications upon the BitcoinSV platform, and developing, operating, and managing distributed computing systems for enterprise users.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

4Q21 Results. TAAL had previously pre-announced 4Q revenue in the $13.75-$14.25 million (CAD) range. Actual revenue came in at $14.7 million, with income before value adjustments of $8.1 million, and net income of $832,100, or $0.02 per share. We had projected revenue of $13.55 million, income before value adjustments of $8.9 million, and net income of $2.6 million, or $0.06 per share.

New Brunswick Facility Sale. TAAL has completed the sale of the New Brunswick facility purchased in December. TAAL will receive $24 million for the facility, which it will lease back. The purchaser has agreed to invest $20 million to upgrade the facility to host hashing operations. The net proceeds from the sale provides TAAL substantial liquidity.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Great Lakes Dredge & Dock (GLDD) – That’s A Lot of Power

Tuesday, May 03, 2022

Great Lakes Dredge & Dock (GLDD)
That’s A Lot of Power

Great Lakes Dredge & Dock Corporation is the largest provider of dredging services in the United States. In addition, Great Lakes is fully engaged in expanding its core business into the rapidly developing offshore wind energy industry. The Company has a long history of performing significant international projects. The Company employs experienced civil, ocean and mechanical engineering staff in its estimating, production and project management functions. In its over 131-year history, the Company has never failed to complete a marine project. Great Lakes owns and operates the largest and most diverse fleet in the U.S. dredging industry, comprised of approximately 200 specialized vessels. Great Lakes has a disciplined training program for engineers that ensures experienced-based performance as they advance through Company operations. The Company’s Incident-and Injury-Free® (IIF®) safety management program is integrated into all aspects of the Company’s culture. The Company’s commitment to the IIF® culture promotes a work environment where employee safety is paramount.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

A New Award. Great Lakes Dredge & Dock’s management announced yesterday that the Company was awarded with a subsea rock instillation project from Empire Offshore Wind, and the Company will be in consortium with Van Oord. The Company will work on the Empire Wind I and II wind farms in the New York, installing rocks to protect and stabilize foundations. The project is estimated to start in the mid 2020s. No details on the contract itself was given.

Providing the Power. The Empire Wind I and II wind farms are situated in New York, as the project is expected to provide over 2 Gigawatts (GW) of renewable energy to the state. For context, New York as of June 2021 has around 2,000 megawatts (or 2 GW) of wind capacity at almost two dozen wind farms according to the EIA. These two wind farms are estimated to power more than one million households in New York….

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Alliance Resource Partners (ARLP) – Solid First Quarter; Outlook Remains Bullish

Tuesday, May 03, 2022

Alliance Resource Partners (ARLP)
Solid First Quarter; Outlook Remains Bullish

ARLP is a diversified natural resource company that generates operating and royalty income from coal produced by its mining complexes and royalty income from mineral interests it owns in strategic oil & gas producing regions in the United States, primarily the Permian, Anadarko and Williston basins. ARLP currently produces coal from seven mining complexes its subsidiaries operate in Illinois, Indiana, Kentucky, Maryland and West Virginia. ARLP also operates a coal loading terminal on the Ohio River at Mount Vernon, Indiana. ARLP markets its coal production to major domestic and international utilities and industrial users and is currently the second largest coal producer in the eastern United States. In addition, ARLP is positioning itself as an energy provider for the future by leveraging its core technology and operating competencies to make strategic investments in the fast growing energy and infrastructure transition.

Mark Reichman, Senior Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Solid first quarter performance. Alliance reported first quarter net income of $36.7 million, or $0.28 per unit compared to $24.7 million, or $0.19 per unit, during the prior year period. The company generated EBITDA of $152.3 million compared to $94.3 million during the prior year period. Results would have been stronger had it not been for transportation constraints that hindered the company’s ability to ship approximately 1.1 million tons of contracted tonnage during the first quarter. These shipments are expected to be delivered throughout the balance of the year. Additionally, financial results were negatively impacted by a $37.3 million one-time non-cash deferred income tax expense and liability to convert the holding company for ARLP’s oil & gas royalty activities, to a corporate taxable entity. Excluding the one-time tax item, adjusted EPU were $0.58.

Updating estimates. We have increased our full year GAAP and adjusted EPU estimates to $3.10 and $3.40, respectively, from $2.85 and $3.15. Our estimates reflect continued strength in commodity prices. We forecast 2022 adjusted EBITDA of $744.6 million and distributable cash flow of $515.1 million….

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.